• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE Back to Search Results
Model Number 8637-40
Device Problem Protective Measures Problem (3015)
Patient Problem Muscle Spasm(s) (1966)
Event Date 10/30/2018
Event Type  malfunction  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Information was received from a foreign healthcare professional (hcp) via a manufacturer representative regarding a patient who was receiving an unknown drug with an unknown concentration at a dose of 276.2 mcg/day via an implantable pump.The indication for use was not provided.It was reported that the patient reported the pump alarm was going off.When the hcp saw the patient it was found that the pump had gone into safe mode delivering only 18 mcg/day.It was noted that the pump elective replacement indicator (eri) was 37 months, and that the patient had been on a stable dose of 276.2 mcg/day for the past couple of years with the last refill in (b)(6) 2018.It was noted that the patient had some spasms but no serious withdrawal symptoms.The hcp put the dose back to the previous dose and two days later the pump was okay and working well, and the patient's symptoms had resolved.It was confirmed that the patient denied any exposure to magnet, mri (magnetic resonance imaging) or similar.No further complications were reported or anticipated.
 
Manufacturer Narrative
A4: reported "approximately 80-90 kg" d6: implant date reported as "(b)(6) 2015" with no specified date.Medtronic, inc.(medtronic) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information in the time allotted and has provided as much information as is available to the company as of the submission date this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic or its employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects" or has "malfunctioned".These words are included in the fda 3500a form and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.Medtronic objects to the use of these words and others like it because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received via follow-up.It was clarified that the alarm/safe mode began on (b)(6) 2018 and the manufacturer representative was notified the next morning.It was confirmed that no reset occurred.The pump was reprogrammed with the previous dose and was checked to confirm that it was continuing correctly.The drug in the pump at the time of the event was baclofen [3000 mcg/ml] at a dose of 276.2 mcg/day.It was also reported that the patient was seen for a refill on (b)(6) 2019 and there were no reported issues and the pump was working fine as expected with optimal symptom control at the same dose.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNCHROMED II
Type of Device
PUMP, INFUSION, IMPLANTED, PROGRAMMABLE
Manufacturer (Section D)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
MDR Report Key8043613
MDR Text Key128249090
Report Number3004209178-2018-24807
Device Sequence Number1
Product Code LKK
Combination Product (y/n)N
PMA/PMN Number
P860004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 01/24/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/28/2016
Device Model Number8637-40
Device Catalogue Number8637-40
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 11/02/2018
Initial Date FDA Received11/06/2018
Supplement Dates Manufacturer Received01/08/2019
Supplement Dates FDA Received01/24/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age50 YR
-
-